MY ACCOUNT | NEWSLETTER |

Poodle-mixes popular breeds: Nationwide


Pet health insurer, Nationwide, has shared a report that points to the popularity of Poodle-mix dogs in recent years, based on analysis of pet insurance information. The report suggests that Goldendoodles, Labradoodles, and other cross-Poodle breeds have become significantly more popular between 2013 to 2021. During that time, Goldendoodles increased by 347% in Nationwide’s insurance data. 

“Veterinary practices have definitely been noticing how many more Doodles they were seeing, and since we track purebreds, crossbreds and mixed-breeds in our policy data, we thought it would be interesting to see just how strong the trend is,” said Dr. Jules Benson, chief veterinary officer at Nationwide. “Those results may not be surprising, but the significant difference in the relative rate of cancer claims in purebred Labs, Goldens and Poodles and their crossbred offspring is definitely a surprise.”

Labradoodles have grown in popularity by 196%, followed by Poodle mixes across the reporting period. As the breeds have become more common, purebred Poodles, Golden Retrievers, and Labrador Retrievers have declined in popularity by 32%, 4%, and 32%, respectively. 

Poodle-mixed breeds also have lower cancer claims, according to Nationwide, which based the data on 1.6 million insurance claims from 2015 to 2021. Both Golden Retrievers and Standard Poodles were at 3.8 times greater risk for a claim of cancer compared to Goldendoodles. Similarly, Standard Poodles and Labrador Retrievers were 2.5 times more likely to have a cancer claim compared to Labradoodles. Across all purebred dogs and mixed-breed dogs, the former was 188.5% more likely to have a cancer claim. 


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Legacy fuels UWVC leadership in comprehensive cancer care

Like0
Dislike0

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top